Because of possible physical incompatibilities, DEPO-MEDROL Sterile Aqueous Suspension should not be diluted or mixed with other solutions. The initial dosage of parenterally administered DEPO-MEDROL will vary from 4 to 120 mg depending on the specific disease entity being treated.
Science synopsis: Kilohertz frequency electrical block of afferent vagus nerve pathways allows targeted stimulation to reduce inflammation in vivo. Lead researcher Yogi Patel (standing), and principal investigator Robert Butera in Butera's lab at Georgia Tech.
This device often reduces the frequency of seizures and can also be activated by a patient or caregiver to stop seizures just as they are beginning. Vagus nerve stimulation can work for any seizure type, but it is most often used for children with debilitating epilepsy. The VNS device often becomes more effective the longer it is in, and physicians typically know within six months if the VNS is helping to control the child's seizures.